Cannabidiol (CBD) has important pharmacological activity, which includes antispasmodic, antioxidant, antithrombotic, and antianxiety properties. CBD has been applied as a health supplement to atherosclerosis. However, CBDs effect on gut microbiota and metabolic phenotype is unclear.
Materials and Methods:
We constructed a high production of cardiovascular risk factors, such as trimethylamine-N-oxide (TMAO) and phenylacetylglutamine (PAGln), in a mouse model using Clostridium sporogenes colonization. We used 16S ribosomal RNA (rRNA) gene sequencing and ultra-high performance liquid chromatography-quadrupole time-of flight mass spectrometry-based metabolomics to evaluate the effect of CBD on gut microbiota and plasma metabolites.
Results:
CBD decreased the levels of creatine kinase (CK), alanine transaminase (ALT), and low-density lipoprotein cholesterol and markedly increased high-density lipoprotein cholesterol. Furthermore, CBD treatment increased the abundance of beneficial bacteria, which include Lachnospiraceae_NK4A136 and Blautia in the gut, but it decreased the levels of TMAO and PAGln in the plasma.
Conclusion:
CBD might have beneficial effects for cardiovascular protection.
Get full access to this article
View all access options for this article.
References
1.
JonssonAL, BackhedF. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol, 2017; 14(2):79–87; doi: 10.1038/nrcardio.2016.183
2.
SkyeSM, ZhuW, RomanoKA, et al.Microbial transplantation with human gut commensals containing cutC is sufficient to transmit enhanced platelet reactivity and thrombosis potential. Circ Res, 2018; 123(10):1164–1176; doi: 10.1161/circresaha.118.313142
3.
AnnunziataG, MaistoM, SchisanoC, et al.Effects of grape pomace polyphenolic extract (Taurisolo®) in reducing TMAO serum levels in humans: Preliminary results from a randomized, placebo-controlled, cross-over study. Nutrients, 2019; 11(1):139; doi: 10.3390/nu11010139
4.
NemetI, SahaPP, GuptaN, et al.A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell, 2020; 180(5):862–877; doi: 10.1016/j.cell.2020.02.016
5.
YeL, CaoZ, WangW, et al.New insights in cannabinoid receptor structure and signaling. Curr Mol Pharmacol, 2019; 12(3):239–248; doi: 10.2174/1874467212666190215112036
6.
TauraF, SirikantaramasS, ShoyamaY, et al.Phytocannabinoids in cannabis sativa: Recent studies on biosynthetic enzymes. Chem Biodivers, 2007; 4(8):1649–1663; doi: 10.1002/cbdv.200790145
7.
StanleyCP, HindWH, O'SullivanSE. Is the cardiovascular system a therapeutic target for cannabidiol?. Br J Clin Pharmacol, 2013; 75(2):313–322; doi: 10.1111/j.1365-2125.2012.04351.x
8.
BabsonKA, SottileJ, MorabitoD. Cannabis, cannabinoids, and sleep: A review of the literature. Curr Psychiatry Rep, 2017; 19(4):23; doi: 10.1007/s11920-017-0775-9
9.
AliferisKA, Bernard-PerronD. Cannabinomics: Application of metabolomics in cannabis (Cannabis sativa L.) research and development. Front Plant Sci, 2020; 11:554; doi: 10.3389/fpls.2020.00554
10.
ProbertF, WalshA, JagielowiczM, et al.Plasma nuclear magnetic resonance metabolomics discriminates between high and low endoscopic activity and predicts progression in a prospective cohort of patients with ulcerative colitis. J Crohns Colitis, 2018; 12(11):1326–1337; doi: 10.1093/ecco-jcc/jjy101
11.
JacobM, MalkawiA, AlbastN, et al.A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism. Anal Chim Acta, 2018; 1025:141–153; doi: 10.1016/j.aca.2018.03.058
12.
XueZ, SharpePL, HongSP, et al.Production of omega-3 eicosapentaenoic acid by metabolic engineering of Yarrowia lipolytica. Nat Biotechnol, 2013; 31(8):734–740; doi: 10.1038/nbt.2622
13.
LiX, SuC, JiangZ, et al.Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. NPJ Biofilms Microbi, 2021; 7(1):36; doi: 10.1038/s41522-021-00205-8
14.
HuangC, FengS, HuoF, et al.Effects of four antibiotics on the diversity of the intestinal microbiota. Microbiol Spectr, 2022; 10(2):e0190421; doi: 10.1128/spectrum.01904-21
15.
HartmannM, HowesCG, VanInsbergheD, et al.Significant and persistent impact of timber harvesting on soil microbial communities in Northern coniferous forests. ISME J, 2012; 6(12):2199–2218; doi: 10.1038/ismej.2012.84
16.
DeSantisTZ, HugenholtzP, LarsenN, et al.Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol, 2006; 72(7):5069–5072; doi: 10.1128/aem.03006-05
17.
ShenX, WangR, XiongX, et al.Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics. Nat Commun, 2019; 10(1):1516; doi: 10.1038/s41467-019-09550-x
18.
CoxLM, YamanishiS, SohnJ, et al.Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell, 2014; 158(4):705–721; doi: 10.1016/j.cell.2014.05.052
19.
PaivaIHR, Duarte-SilvaE, PeixotoCA. The role of prebiotics in cognition, anxiety, and depression. Eur Neuropsychopharmacol, 2020; 34:1–18; doi: 10.1016/j.euroneuro.2020.03.006
20.
HuangP, LiuY. A reasonable diet promotes balance of intestinal microbiota: Prevention of precolorectal cancer. Biomed Res Int, 2019; 2019:3405278; doi: 10.1155/2019/3405278
21.
VaccaM, CelanoG, CalabreseFM, et al.The controversial role of human gut Lachnospiraceae. Microorganisms, 2020; 8(4):573; doi: 10.3390/microorganisms8040573
22.
ZhangJ, SongL, WangY, et al.Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats. J Gastroenterol Hepatol, 2019; 34(8):1368–1376; doi: 10.1111/jgh.14536
23.
YangYN, WangQC, XuW, et al.The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression. Biomed Pharmacother, 2022; 155:113749; doi: 10.1016/j.biopha.2022.113749
24.
LiuH, WangJ, HeT, et al.Butyrate: A double-edged sword for health?. Adv Nutr, 2018; 9(1):21–29; doi: 10.1093/advances/nmx009
ParkerBJ, WearschPA, VelooACM, et al.The genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol, 2020; 11:906; doi: 10.3389/fimmu.2020.00906
27.
AgusA, ClémentK, SokolH. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut, 2021; 70(6):1174–1182; doi: 10.1136/gutjnl-2020-323071
28.
HuangW, ChoKY, MengD, et al.The impact of indole-3-lactic acid on immature intestinal innate immunity and development: A transcriptomic analysis. Sci Rep, 2021; 11(1):8088; doi: 10.1038/s41598-021-87353-1
29.
ArakiM, NakagawaY, OishiA, et al.The peroxisome proliferator-activated receptor α (PPARα) agonist pemafibrate protects against diet-induced obesity in mice. Int J Mol Sci, 2018; 19(7):2148; doi: 10.3390/ijms19072148
30.
JoshuaJ, KalyanaramanH, MaratheN, et al.Nitric oxide as a mediator of estrogen effects in osteocytes. Vitam Horm, 2014; 96:247–263; doi: 10.1016/b978-0-12-800254-4.00010-6
31.
ShengW, JiG, ZhangL. The effect of lithocholic acid on the gut-liver axis. Front Pharmacol, 2022; 13:910493; doi: 10.3389/fphar.2022.910493
32.
BennettBJ, de Aguiar VallimTQ, WangZ, et al.Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab, 2013; 17(1):49–60; doi: 10.1016/j.cmet.2012.12.011
33.
ZhuWF, GregoryJ, OrgE, et al.Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell, 2016; 165(1):111–124; doi: 10.1016/j.cell.2016.02.011
34.
WangZ, KlipfellE, BennettBJ, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 2011; 472(7341):57–63; doi: 10.1038/nature09922
35.
AllertonTD, ProctorDN, StephensJM, et al.l-Citrulline supplementation: Impact on cardiometabolic health. Nutrients, 2018; 10(7):921; doi: 10.3390/nu10070921
36.
NowińskiA, UfnalM. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?. Nutrition, 2018; 46:7–12; doi: 10.1016/j.nut.2017.08.001
37.
DoddD, SpitzerMH, Van TreurenW, et al.A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature, 2017; 551(7682):648–652; doi: 10.1038/nature24661
38.
RajendranV, KalitaP, ShuklaH, et al.Aminoacyl-tRNA synthetases: Structure, function, and drug discovery. Int J Biol Macromol, 2018; 111:400–414; doi: 10.1016/j.ijbiomac.2017.12.157
39.
MaedaH, DudarevaN. The shikimate pathway and aromatic amino acid biosynthesis in plants. Annu Rev Plant Biol, 2012; 63:73–105; doi: 10.1146/annurev-arplant-042811-105439
40.
GojdaJ, CahovaM. Gut microbiota as the link between elevated BCAA serum levels and insulin resistance. Biomolecules, 2021; 11(10):1414; doi: 10.3390/biom11101414
